Atletico Madrid are reportedly keen on signing 25-year-old Liverpool striker Darwin Nunez in the summer transfer window.
Darwin Nunez has faced a lot of criticism for his inconsistent performances, and he has picked up just 14 goal contributions this season. However, the Uruguayan international is a target for several European bigwigs despite his inconsistencies.
According to a report by Spanish outlet Fichajes, Atletico Madrid want to sign the Liverpool attacker on an loan deal with an obligation to buy worth around €40 million.
It will be interesting to see if Liverpool are willing to accept such an offer. Darwin Nunez could certainly use a fresh start at this stage of his career, and a move to the Spanish club could be ideal for him. Diego Simeone could bring out the best in the South American. It remains to be seen whether Liverpool are prepared to let him leave on loan with an obligation to buy.
Atletico Madrid will offer €40 million for the striker at the end of his loan spell. Liverpool paid a club record fee to sign the player, and it remains to be seen whether they are ready to accept a considerable loss on him.
Liverpool should remain patient with Nunez
Darwin Nunez has impressed with his overall footballing acumen, but his finishing ability and decision making in the final third leaves a lot to be desired. The striker is still only 25 with room for development. It remains to be seen when the Liverpool decide to remain patient with him for now.
Meanwhile, Atletico Madrid need more depth in the final third, and Nunez could be the ideal partner for Julian Alvarez in the attacking unit. The opportunity to move to La Liga could be quite attractive for the South American striker. He might be open to the move and it remains to be seen how the situation develops.
Nunez was regarded as one of the best young attackers in world football when he was at Benfica. He has not been able to replicate that form at Liverpool, but he has shown his quality in glimpses. It will be interesting to see if he can be more consistent in the coming weeks.